Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 3546 entries
View as:

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT02986854 Org: User:
Start: 12/08/16 End: 12/07/17 Due: 12/07/18

Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT01381536 Org: User:
Start: 07/20/10 End: 11/27/10 Due: 11/27/11

Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Phase: N/A Priority: Normal
NCT ID: NCT00430157 Org: User:
Start: 01/31/07 End: - Due: -

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Phase: N/A Priority: Normal
NCT ID: NCT01209078 Org: User:
Start: 08/17/10 End: 01/18/11 Due: 01/18/12

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Phase: N/A Priority: Normal
NCT ID: NCT00771615 Org: User:
Start: 10/16/08 End: 12/04/09 Due: 12/04/10

First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02647281 Org: User:
Start: 12/17/15 End: 01/03/17 Due: 01/03/18

GSK2018682 FTIH in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01387217 Org: User:
Start: 05/21/10 End: 12/20/10 Due: 12/20/11

Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03329573 Org: User:
Start: 05/30/18 End: 08/03/18 Due: 08/03/19

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01527123 Org: User:
Start: 02/28/12 End: 06/01/12 Due: 06/01/13

P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00390845 Org: User:
Start: 08/30/06 End: 08/11/08 Due: 08/11/09

Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults

Phase: N/A Priority: Normal
NCT ID: NCT00506350 Org: User:
Start: 08/01/07 End: 10/12/09 Due: 10/12/10

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Phase: N/A Priority: Normal
NCT ID: NCT00489554 Org: User:
Start: 07/03/07 End: 03/31/08 Due: 03/31/09

An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode

Phase: N/A Priority: Normal
NCT ID: NCT01653509 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

Phase: N/A Priority: Normal
NCT ID: NCT02547974 Org: User:
Start: 08/31/15 End: 03/31/17 Due: 03/31/18

Patch Test of Benzalkonium Chloride Disinfectant Spray

Phase: N/A Priority: Normal
NCT ID: NCT01762982 Org: User:
Start: 02/29/12 End: 02/29/12 Due: 02/28/13

Open-Label Extension Study of GSK1605786A

Phase: N/A Priority: Normal
NCT ID: NCT01318993 Org: User:
Start: 04/01/11 End: 10/29/13 Due: 10/29/14

Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

Phase: N/A Priority: Normal
NCT ID: NCT00938327 Org: User:
Start: 08/03/09 End: 04/23/10 Due: 04/23/11

Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00380354 Org: User:
Start: 09/30/06 End: 06/30/07 Due: 06/30/08

GSK1120212 Food-effect Study

Phase: N/A Priority: Normal
NCT ID: NCT01371487 Org: User:
Start: 05/02/11 End: 09/30/11 Due: 09/30/12

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

Phase: N/A Priority: Normal
NCT ID: NCT03151395 Org: User:
Start: 08/25/17 End: 04/06/20 Due: 04/06/21

LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

Phase: N/A Priority: Normal
NCT ID: NCT00240526 Org: User:
Start: 10/31/03 End: 03/31/10 Due: 03/31/11

Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants

Phase: N/A Priority: Normal
NCT ID: NCT01231503 Org: User:
Start: 01/13/11 End: 12/23/14 Due: 12/23/15

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

Phase: N/A Priority: Normal
NCT ID: NCT00318149 Org: User:
Start: 10/10/05 End: 05/14/06 Due: 05/14/07

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

Phase: N/A Priority: Normal
NCT ID: NCT03029247 Org: User:
Start: 07/27/17 End: 07/09/20 Due: 07/09/21

Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP

Phase: N/A Priority: Normal
NCT ID: NCT01868035 Org: User:
Start: 05/31/00 End: 10/31/12 Due: 10/31/13